Ian Mortimer

President & CEO, Director, Xenon Pharmaceuticals Inc.

Bought, 12 months

$1.1M

Sold, 12 months

$20.3M

Companies

Latest trade

Sep 30, 2026

Companies

Xenon Pharmaceuticals Inc.President & CEO, Director +$1.1M −$21.3M

Trades

XENE Bought 30,000 shares at $37.38 $1.1M Sep 30

XENE Sold 7,308 shares at $55.23 · planned $0.4M Mar 13

XENE Sold 11,269 shares at $60.11 · planned $0.7M Mar 10

XENE Sold 270,000 shares at $60.33 · planned $16.3M Mar 9

XENE Sold 40,000 shares at $44.43 · planned $1.8M Jan 2

XENE Sold 10,830 shares at $45.73 · planned $0.5M Dec 8

XENE Sold 14,375 shares at $45.03 · planned $0.6M Dec 5

XENE Sold 97 shares at $45.01 · planned $0.0M Nov 28

XENE Sold 25,000 shares at $40.16 · planned $1.0M Oct 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.